In responding to requests from commissioning groups, government departments, industry, researchers, specialist societies, the media, training authorities and our own core strategy, it is vital that we as the specialist society in Nuclear Medicine are able to produce meaningful and correct data.
The importance of holding such data is illustrated by the shortages in the supply chain for 99mTc and also in the case of the enforcement of the patent for the use of Dotatate. Information to approach key individuals in government was difficult to obtain and our hope is that the BNMS survey will afford us an accessible source of accurate data both for imaging, non-imaging diagnostics and for therapy involving radioisotopes.
It is very important that the survey is completed by as many Nuclear Medicine/Radiopharmacy departments as possible, so that the growing pressures to deliver more output but with less resources can be monitored in a consistent way.
The value of having good quality and accurate data cannot be underestimated and this information (or the lack of it) influences decisions regarding manpower and resources.
To help us make this run as smoothly as possible, please keep us informed of any changes to your departmental contacts or if you think your department hasn't been contacted by emailing Caroline Oxley .